Coverage
-
December 20, 2011
A Delaware federal judge on Monday dismissed consolidated patent litigation between Pfizer Inc. and Sandoz Inc. over Pfizer's blood pressure and cholesterol drug Caduet, after they agreed to drop the dispute.
1 other articles on this case.
View all »